![Francois Nader](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francois Nader
Directeur/Membre du Conseil chez
MODERNA, INC.
Fortune : 2 M $ au 31/05/2026
Profil
François Nader est un homme d'affaires qui a fondé Jesra Advisors LLC et qui a été à la tête de 6 entreprises différentes. Il occupe le poste de président non exécutif pour Acceleron Pharma, Inc, de président pour Talaris Therapeutics, Inc et de directeur général de Jesra Advisors LLC. Le Dr Nader est également membre du conseil d'administration d'Alexion Pharmaceuticals, Inc. et de la Chambre de commerce du New Jersey, d'Arrett Neurosciences, Inc. et de Moderna, Inc. Auparavant, le Dr Nader a occupé les postes suivants : administrateur de BioNJ, Inc, médecin en chef de Care Capital LLC, vice-président de Jesra Foundation, Inc, président non exécutif de Prevail Therapeutics, Inc, président, directeur général et administrateur de NPS Pharmaceuticals, Inc, vice-président principal des marchés intégrés de la santé chez Aventis Pharmaceuticals, Inc, chef des opérations commerciales mondiales chez Rhône-Poulenc Basic Chemical Co. et vice-président principal des marchés intégrés de la santé chez Hoechst Marion Roussel, Inc. François Nader est titulaire d'un MBA de l'Université du Tennessee et d'un doctorat de l'Université Saint-Joseph.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MODERNA, INC. 0,01% | 06/05/2026 | 32 781 ( 0,01% ) | 2 M $ | 31/05/2026 |
Postes actifs de Francois Nader
| Sociétés | Poste | Début |
|---|---|---|
| MODERNA, INC. | Directeur/Membre du Conseil | 11/12/2019 |
Neurvati Neurosciences, Inc.
 Neurvati Neurosciences, Inc. BiotechnologyHealth Technology Develops therapies for neurological and psychiatric disorders | Directeur/Membre du Conseil | - |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Directeur/Membre du Conseil | 01/11/2021 |
Arrett Neurosciences, Inc.
 Arrett Neurosciences, Inc. Medical/Nursing ServicesHealth Services Provides treatments to rett syndrome patients | Directeur/Membre du Conseil | - |
Jesra Advisors LLC
 Jesra Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Directeur Général | 01/02/2015 |
New Jersey Chamber of Commerce Foundation, Inc.
 New Jersey Chamber of Commerce Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Directeur/Membre du Conseil | 30/01/2014 |
Anciens postes connus de Francois Nader
| Sociétés | Poste | Fin |
|---|---|---|
| BENEVOLENTAI S.A. | Directeur Général | 24/01/2024 |
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Président | 01/01/2024 |
| TOUE BIOPAR | Président | 01/01/2023 |
| ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Francois Nader
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacture, marketing and sale of transdermal pharmaceutical products | Commercial Services |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care capital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and specialty pharmaceuticals. It provides financing for growth and buyout capital transactions with an investment size of USD 5 - 20 million. | Finance |
Rhone-Poulenc Basic Chemical Co.
 Rhone-Poulenc Basic Chemical Co. Environmental ServicesIndustrial Services Operates incineration and regeneration process, and other hazardous waste operations | Industrial Services |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Jersey Chamber of Commerce Foundation, Inc.
New Jersey Chamber of Commerce Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The HealthCare Institute of New Jersey is a trade association representing research-based biopharmaceutical, medical device, and diagnostic companies. The private company is based in Bridgewater, NJ. It advocates for policies that promote innovation, patient access to advanced medical products, and job creation within the life sciences sector. The organization collaborates with government, academia, and stakeholders to foster an innovation ecosystem and raise awareness of the industry’s clinical, economic, and social impact. It emphasizes corporate social responsibility, including commitments to philanthropy, environmental sustainability, ethical practices, and community engagement. The institute leads initiatives in diversity, equity, and inclusion, aiming to transform corporate culture, diversify supply chains, and address health inequities. It provides patient advocacy and assistance programs, such as the rx4nj partnership and njsave, which connect patients to prescription assistance and other support programs. Christine Buteas has been the CEO of the company since 2024. | |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Pharmaceuticals: MajorHealth Technology Develops and produces nuclear medicine and radioligand therapies | Health Technology |
St. Joseph University
 St. Joseph University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Jesra Foundation, Inc. | |
BenevolentAI Ltd.
BenevolentAI Ltd. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery company | Technology Services |
Jesra Advisors LLC
Jesra Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Arrett Neurosciences, Inc.
Arrett Neurosciences, Inc. Medical/Nursing ServicesHealth Services Provides treatments to rett syndrome patients | Health Services |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
Neurvati Neurosciences, Inc.
Neurvati Neurosciences, Inc. BiotechnologyHealth Technology Develops therapies for neurological and psychiatric disorders | Health Technology |
